IL-17 integrates multiple self-reinforcing, feed-forward mechanisms through the RNA-binding protein Arid5a
Open accessThe DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Abstract
). These TFs in turn transactivated IL-17-dependent promoters. Together, these data indicated that Arid5a orchestrates a feed-forward amplification loop, which promoted IL-17 signaling by controlling mRNA stability and translation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Regnase-1 binds to IL-17- and LPS-induced gene transcripts via stem-loop structures in the 3’ UTR in a site overlapping with Arid5a, another IL-17-induced RBP”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Amatya et al., 2018
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Rather, IL-17 employs the RBPs HuR and Arid5a to prolong the half-life of certain target transcripts.”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Amatya et al., 2018
In the citing paper
“The IL-17-driven pathway that controls RNA stability is initiated by phosphorylation of Act1 by Ikki (IKKe), directing its association to TRAF2 and TRAF5. and mobilizing multiple RBPs”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Amatya et al., 2018
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099
The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing
Gaffen, S. L., Jain, R., Garg, A. V., & Cua, D. J. (2014) · Nature reviews. Immunology · doi:10.1038/nri3707 · Cited by 1,585
Self-citationInnate IL-17-producing cells: the sentinels of the immune system
Cua, D. J., & Tato, C. M. (2010) · Nature Reviews Immunology · doi:10.1038/nri2800 · Cited by 1,578
Functional Specialization of Interleukin-17 Family Members
Iwakura, Y., Ishigame, H., Saijo, S., & Nakae, S. (2011) · Immunity · doi:10.1016/j.immuni.2011.02.012 · Cited by 1,289 · cited 2×
“DISCUSSION IL-17 signaling dominantly occurs in epithelial and mesenchymal cell types (39), and thus, IL-17 functions as a bridge between the immune system and inflamed tissue.”
BackgroundDickson, M. A., Hahn, W. C., Ino, Y., Ronfard, V., Wu, J. Y., Weinberg, R. A., Louis, D. N., Li, F. P., & Rheinwald, J. G. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.4.1436-1447.2000 · Cited by 1,104
Conti, H. R., Shen, F., Nayyar, N., Stocum, E., Sun, J. N., Lindemann, M. J., Ho, A. W., Hai, J. H., Yu, J. J., Jung, J. W., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20081463 · Cited by 1,024 · cited 2×
“albicans (CAF2-1) for 75 min under anesthesia (23).”
BackgroundSelf-citationBrodalumab, an Anti–Interleukin-17–Receptor Antibody for Psoriasis
Papp, K. A., Leonardi, C., Menter, A., Ortonne, J.-P., Krueger, J. G., Kricorian, G., Aras, G., Li, J., Russell, C. B., Thompson, E. H. Z., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1109017 · Cited by 941 · cited 1×
“Blocking IL-17 is remarkably effective in treating psoriasis and is under evaluation for other autoimmune conditions (59, 60).”
Anti–Interleukin-17 Monoclonal Antibody Ixekizumab in Chronic Plaque Psoriasis
Leonardi, C., Matheson, R., Zachariae, C., Cameron, G., Li, L., Edson-Heredia, E., Braun, D., & Banerjee, S. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1109997 · Cited by 936 · cited 1×
“Blocking IL-17 is remarkably effective in treating psoriasis and is under evaluation for other autoimmune conditions (59, 60).”
BackgroundInterleukin-17 and its target genes: mechanisms of interleukin-17 function in disease
Onishi, R. M., & Gaffen, S. L. (2010) · Immunology · doi:10.1111/j.1365-2567.2009.03240.x · Cited by 894
Self-citationCrooke, S. T., Witztum, J. L., Bennett, C. F., & Baker, B. F. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.03.004 · Cited by 841
Cited by
The IL-17 Family of Cytokines in Health and Disease
McGeachy, M. J., Cua, D. J., & Gaffen, S. L. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.021 · Cited by 1,443
“These RBPs bind 3’ UTR motifs and counteracting the activity of de-stabilizing ribonucleases (see below) (Amatya et al., 2018; Herjan et al., 2013; Puel and Casanova, 2018).”
BackgroundInfluentialSelf-citationIL-17 receptor–based signaling and implications for disease
Li, X., Bechara, R., Zhao, J., McGeachy, M. J., & Gaffen, S. L. (2019) · Nature Immunology · doi:10.1038/s41590-019-0514-y · Cited by 548
Self-citationThe IL-17 family in diseases: from bench to bedside
Huangfu, L., Li, R., Huang, Y., & Wang, S. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01620-3 · Cited by 452
Historical overview of the interleukin-6 family cytokine
Kang, S., Narazaki, M., Metwally, H., & Kishimoto, T. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20190347 · Cited by 360
The role of interleukin-17 in tumor development and progression
Zhao, J., Chen, X., Herjan, T., & Li, X. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20190297 · Cited by 248
“…regions that can be recognized by RNA-binding proteins (e.g., SF2) and mediate the sequential deadenylation, decapping, and ultimately exonucleolytic degradation of the RNA (Amatya et al., 2018; Bulek et al., 2011; Garg et al., 2015; Herjan et al., 2013, 2018; Somma et al., 2015; Sun et al., 2011).”
BackgroundKrueger, J. G., Wharton, K. A., Schlitt, T., Suprun, M., Torene, R. I., Jiang, X., Wang, C. Q., Fuentes-Duculan, J., Hartmann, N., Peters, T., et al. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2019.04.029 · Cited by 188
“In it, TH17-derived IL-17A and IL17F induce massive overproduction of inflammatory products, such as IL-17C, IL-36, IL-19, CCL20, CXCL chemokines, and S100 proteins, in psoriatic KCs, in turn altering resident skin cell homeostasis and further attracting activated leukocyte subsets to maintain plaques.(7,16,17) KC-pro…”
BackgroundThe biological basis of disease recurrence in psoriasis: a historical perspective and current models
Puig, L., Costanzo, A., Muñoz‐Elías, E. J., Jazra, M., Wegner, S., Paul, C. F., & Conrad, C. (2021) · British Journal of Dermatology · doi:10.1111/bjd.20963 · Cited by 124
The metabolism-modulating activity of IL-17 signaling in health and disease
Bechara, R., McGeachy, M. J., & Gaffen, S. L. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20202191 · Cited by 104
Self-citationTRAF Regulation of IL-17 Cytokine Signaling
Swaidani, S., Liu, C., Zhao, J., Bulek, K., & Li, X. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01293 · Cited by 110
“Notably, a recent study has shown that IL17A stimulation induces the RNA binding protein Arid5a, which is recruited by TRAF2 to counteract Regnase-1-mediated mRNA degradation (53).”
BackgroundRegulation of γδ T Cell Effector Diversification in the Thymus
Parker, M. E., & Ciofani, M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00042 · Cited by 99
“IFNγ production by γδ T cells is associated with clearance of intracellular pathogens and anti-tumor responses, while IL-17A production is linked to clearance of extracellular bacteria and fungi (7, 8).”
BackgroundPrinz, I., Sandrock, I., & Mrowietz, U. (2019) · The Journal of Experimental Medicine · doi:10.1084/jem.20191397 · Cited by 91
Bechara, R., Amatya, N., Bailey, R. D., Li, Y., Aggor, F. E. Y., Li, D.-D., Jawale, C. V., Coleman, B. M., Dai, N., Gokhale, N. S., et al. (2021) · Science Immunology · doi:10.1126/sciimmunol.abd1287 · Cited by 89
“Luc assays were performed with the Dual-Luciferase Reporter Assay System (Promega) and normalized to a Renilla Luc control (17).”
BackgroundMethodInfluentialSelf-citationRNA Recognition and Immunity—Innate Immune Sensing and Its Posttranscriptional Regulation Mechanisms
Uehata, T., & Takeuchi, O. (2020) · Cells · doi:10.3390/cells9071701 · Cited by 92
“Regnase-1-mediated mRNA destabilization is antagonized by Arid5a, which is another RBP [141,142].”
BackgroundArid5a, an RNA-Binding Protein in Immune Regulation: RNA Stability, Inflammation, and Autoimmunity
Nyati, K. K., Zaman, M. M.-U., Sharma, P., & Kishimoto, T. (2020) · Trends in Immunology · doi:10.1016/j.it.2020.01.004 · Cited by 93
Control of RNA Stability in Immunity
Akira, S., & Maeda, K. (2021) · Annual Review of Immunology · doi:10.1146/annurev-immunol-101819-075147 · Cited by 92
Current understanding of the role of tyrosine kinase 2 signaling in immune responses
Muromoto, R., Oritani, K., & Matsuda, T. (2022) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v13.i1.1 · Cited by 68
The central inflammatory regulator IκBζ: induction, regulation and physiological functions
Feng, Y., Chen, Z., Xu, Y., Han, Y., Jia, X., Wang, Z., Zhang, N., & Lv, W. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1188253 · Cited by 66
“The RNA-binding protein AT-rich interactive domain-containing protein 5a (Arid5a) binds to the 3’-UTR of IkBz mRNA and promotes the translation of IkBz (21).”
BackgroundIL-17–induced HIF1α drives resistance to anti–PD-L1 via fibroblast-mediated immune exclusion
Chen, X., Zhao, J., Herjan, T., Hong, L., Liao, Y., Liu, C., Vasu, K., Wang, H., Thompson, A., Fox, P. L., et al. (2022) · Journal of Experimental Medicine · doi:10.1084/jem.20210693 · Cited by 53
“is the activation of posttranscriptional regulation for a subset of target genes (Amatya et al., 2018; Herjan et al., 2018).”
BackgroundMetwally, H., Tanaka, T., Li, S., Parajuli, G., Kang, S., Hanieh, H., Hashimoto, S., Chalise, J. P., Gemechu, Y., Standley, D. M., et al. (2020) · Science Signaling · doi:10.1126/scisignal.aay0574 · Cited by 55
Interleukin-17 as a key player in neuroimmunometabolism
Douglas, A., Stevens, B., & Lynch, L. (2023) · Nature Metabolism · doi:10.1038/s42255-023-00846-3 · Cited by 49
Roles of RNA-binding proteins in immune diseases and cancer
Hashimoto, S., & Kishimoto, T. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.03.017 · Cited by 53
Mechanisms of Corticosteroid Resistance in Type 17 Asthma
Hong, L., Herjan, T., Bulek, K., Xiao, J., COMHAIR, S. A. A., ERZURUM, S. C., Li, X., & Liu, C. (2022) · The Journal of Immunology · doi:10.4049/jimmunol.2200288 · Cited by 47
The Role of IL-17 in the Pathogenesis of Oral Squamous Cell Carcinoma
Ladjevac, N., Milovanović, M., Jevtović, A., Arsenijević, D., Stojanović, B., Stojanovic, M. D., Stojanović, B., Arsenijević, N., Arsenijević, A., & Milovanović, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24129874 · Cited by 39
“Furthermore, Act1 facilitates the binding of HuR to mRNA, enabling the movement of mRNAs into polyribosomes for translation [85].”
BackgroundRNA binding proteins in the control of autoimmune diseases
Yoshinaga, M., & Takeuchi, O. (2019) · Immunological Medicine · doi:10.1080/25785826.2019.1655192 · Cited by 38
Systematic analysis of the IL ‐17 receptor signalosome reveals a robust regulatory feedback loop
Draberova, H., Janusova, S., Knizkova, D., Semberova, T., Pribikova, M., Ujevic, A., Harant, K., Knapkova, S., Hrdinka, M., Fanfani, V., et al. (2020) · The EMBO Journal · doi:10.15252/embj.2019104202 · Cited by 35
“…of mRNA transcripts via ACT1 and TRAF2/5, which regulate mRNA stability either directly, or by modulating the activity of mRNA binding proteins ARID5A and HuR, splicing factor SF2, and endoribonuclease Regnase-1 (Sun et al , 2011; Herjan et al , 2013, 2018; Somma et al , 2015; Amatya et al , 2018).”
Post‐transcriptional control of immune responses and its potential application
Yoshinaga, M., & Takeuchi, O. (2019) · Clinical & Translational Immunology · doi:10.1002/cti2.1063 · Cited by 33
“Moreover, Arid5a is reported to promote translation of Nfkbiz and Cebpb mRNA.(45) Thus, these studies demonstrate that Arid5a is a positive regulator of immune responses which antagonises Regnase-1 function.”
BackgroundFeedback regulation of Arid5a and Ppar-γ2 maintains adipose tissue homeostasis
Chalise, J. P., Hashimoto, S., Parajuli, G., Kang, S., Singh, S. K., Gemechu, Y., Metwally, H., Nyati, K. K., Dubey, P. K., Zaman, M. M.-U., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1906712116 · Cited by 34
“N. Amatya et al., IL-17 integrates multiple self-reinforcing, feed-forward mechanisms through the RNA binding protein Arid5a.”
BackgroundBowman, W. S., Schmidt, R. J., Sanghar, G. K., Thompson, G. R., Ji, H., Zeki, A. A., & Haczku, A. (2024) · International Archives of Allergy and Immunology · doi:10.1159/000536578 · Cited by 26
Recent Advances in the Role of Arid5a in Immune Diseases and Cancer
Nyati, K. K., & Kishimoto, T. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.827611 · Cited by 30
“The expression of Arid5a is increased through a feed-forward loop in IL17-stimulated cells, which further triggers the recruitment of Arid5a to TRAF2 (23, 24, 48).”
BackgroundEmerging role of IκBζ in inflammation: Emphasis on psoriasis
Gautam, P., Maenner, S., Cailotto, F., Reboul, P., Labialle, S., Jouzeau, J., Bourgaud, F., & Moulin, D. (2022) · Clinical and Translational Medicine · doi:10.1002/ctm2.1032 · Cited by 32
Post-transcriptional checkpoints in autoimmunity
Bechara, R., Vagner, S., & Mariette, X. (2023) · Nature Reviews Rheumatology · doi:10.1038/s41584-023-00980-y · Cited by 25
IκB-ζ Expression Requires Both TYK2/STAT3 Activity and IL-17–Regulated mRNA Stabilization
Muromoto, R., Tawa, K., Ohgakiuchi, Y., Sato, A., Saino, Y., Hirashima, K., Minoguchi, H., Kitai, Y., Kashiwakura, J., Shimoda, K., et al. (2019) · ImmunoHorizons · doi:10.4049/immunohorizons.1900023 · Cited by 27
14-3-3ζ–TRAF5 axis governs interleukin-17A signaling
McGowan, J., Peter, C., Kim, J. P., Popli, S., Veerman, B., Saul‐McBeth, J., Conti, H. R., Pruett‐Miller, S. M., Chattopadhyay, S., & Chakravarti, R. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2008214117 · Cited by 24
IκBζ is an essential mediator of immunity to oropharyngeal candidiasis
Taylor, T. C., Coleman, B. M., Arunkumar, S. P., Dey, I., Dillon, J. T., Ponde, N. O., Poholek, A. C., Schwartz, D. M., McGeachy, M. J., Conti, H. R., et al. (2023) · Cell Host & Microbe · doi:10.1016/j.chom.2023.08.016 · Cited by 24
Self-citationMissense Variants Reveal Functional Insights Into the Human ARID Family of Gene Regulators
Deák, G., & Cook, A. G. (2022) · Journal of Molecular Biology · doi:10.1016/j.jmb.2022.167529 · Cited by 20
“ARID5A is thought to be an RNAbinding protein (39, 40).”
BackgroundRole and functional mechanisms of IL‑17/IL‑17R signaling in pancreatic cancer (Review)
Liu, W., Wang, X., & Wu, W. (2024) · Oncology Reports · doi:10.3892/or.2024.8803 · Cited by 22
“Similarly, the expression of Arid5a, an RNA‑binding protein, is upregulated by IL‑17, which competes with Regnase‑1 to stabilize IL‑17‑induced tran‑ scripts by binding to TRAF2 (54).”
BackgroundThe RNA-Binding Protein IMP2 Drives a Stromal-Th17 Cell Circuit in Autoimmune Neuroinflammation
Bechara, R., Amatya, N., Majumder, S., Zhou, C., Li, Y., Liu, Q., McGeachy, M. J., & Gaffen, S. L. (2022) · JCI Insight · doi:10.1172/jci.insight.152766 · Cited by 18
“Cells were washed with PBS and treated with 10 μg/ml actinomycin D (ActD; Sigma-Aldrich) ± 200 ng/ml IL-17 as described (26).”
BackgroundMethodSelf-citationThe Nuclear NF-κB Regulator IκBζ: Updates on Its Molecular Functions and Pathophysiological Roles
Yamazaki, S. (2024) · Cells · doi:10.3390/cells13171467 · Cited by 19
“…regulation via a stem-loop structure in the 3 ′ region of Nfkbiz , the RNA-binding protein Arid5a counteracts the Regnase-1-mediated Similar to Nfkbiz , the expression of Zc3h12a and Arid5a is upregulated following IL-17 stimulation [27,33,34], indicating a tight control by multiple factors.”
BackgroundThe RNA binding protein Arid5a drives IL-17–dependent autoantibody-induced glomerulonephritis
Li, Y., Vyas, S., Mehta, I. D., Asada, N., Dey, I., Taylor, T. C., Bechara, R., Amatya, N., Aggor, F. E. Y., Coleman, B. M., et al. (2024) · The Journal of Experimental Medicine · doi:10.1084/jem.20240656 · Cited by 15
“…stabilizes Il6 and chemokine mRNAs in fibroblasts (Amatya et al., 2018) and stabilizes transcripts that drive Th17 cell differentiation including Il6 and Stat3 (Amatya et al., 2018; Hanieh et al., 2018; Li et al., 2023; Masuda et al., 2013, 2016; Nyati et al., 2017, 2020; Parajuli et al., 2021).”
InfluentialSelf-citationOhgakiuchi, Y., Saino, Y., Muromoto, R., Komori, Y., Sato, A., Hirashima, K., Kitai, Y., Kashiwakura, J., Oritani, K., & Matsuda, T. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.11.036 · Cited by 19
“The RNA binding protein Arid5a has been demonstrated to be induced upon IL-17 stimulation and to stabilize IL-17–induced cytokine transcripts by binding to their 3′-untranslated regions (3′-UTRs) and also counteract mRNA degradation mediated by Regnase-1 [11].”
BackgroundGut Commensal-Induced IκBζ Expression in Dendritic Cells Influences the Th17 Response
Michaelis, L., Treß, M., Löw, H.-C., Klees, J., Klameth, C., Lange, A., Grießhammer, A., Schäfer, A., Menz, S., Steimle, A., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.612336 · Cited by 17
“Transcription of the Nfkbiz gene is rapidly induced as primary NFkB response gene upon TLR- and cytokinereceptor signaling (18, 19, 21).”
BackgroundArid5a Mediates an IL-17–Dependent Pathway That Drives Autoimmunity but Not Antifungal Host Defense
Taylor, T. C., Li, Y., Li, D., Majumder, S., McGeachy, M. J., Biswas, P. S., Gingras, S., & Gaffen, S. L. (2022) · The Journal of Immunology · doi:10.4049/jimmunol.2200132 · Cited by 14
Self-citationRegulation of NFKBIZ gene promoter activity by STAT3, C/EBPβ, and STAT1
Muromoto, R., Sato, A., Komori, Y., Nariya, K., Kitai, Y., Kashiwakura, J., & Matsuda, T. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.04.140 · Cited by 13
Alzahrani, A. M., & Hanieh, H. (2020) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2020.10.007 · Cited by 13
“Arid5a triggers IL-17 signaling and enhances the mRNA stability of Il6, chemokine (C-X-C motif) ligand 1 (Cxcl1) and Cxcl5 by binding to their 30UTR and counteracting the RNase activity of Regnase-1 (Amatya et al., 2018).”
Kidney-Specific Interleukin-17 Responses During Infection and Injury
Peroumal, D., & Biswas, P. S. (2023) · Annual Review of Immunology · doi:10.1146/annurev-immunol-052523-015141 · Cited by 12
Chen, S., Fan, H., Ran, C., Hong, Y., Feng, H., Yue, Z., Zhang, H., Pontarotti, P., Xu, A., & Huang, S. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2400903121 · Cited by 13
Trevejo-Nuñez, G., Lin, B., Fan, L., Aggor, F. E. Y., Biswas, P. S., Chen, K., & Gaffen, S. L. (2022) · mBio · doi:10.1128/mbio.03792-21 · Cited by 11
Self-citationHashimoto, A., & Hashimoto, S. (2024) · Cancers · doi:10.3390/cancers16234094 · Cited by 13
“Arid5a deficiency was also shown to stabilize other immune-regulating mRNAs, such as signal transducer and activator of transcription 3 ( Stat3 ), T-box transcription factor 21 , Ox40 (also known as TNFRSF4 ), and Il17 [372–375].”
The emerging role of Arid5a in cancer: A new target for tumors
Nyati, K. K., & Kishimoto, T. (2022) · Genes & Diseases · doi:10.1016/j.gendis.2021.12.012 · Cited by 10
“Arid5a is highly expressed in the nucleus, but stimulation of TLR4 and IL-17 signaling induces its translocation to the cytoplasm.(7,26) In stromal ST2 cells, Arid5a was found to be increased only in cytoplasmic fraction after IL-17 stimulation.”
BackgroundHashimoto, A., Handa, H., Hata, S., & Hashimoto, S. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1005566 · Cited by 11
Kübelbeck, T., Wichmann, N. O., Raj, T., Raj, C., Ohnmacht, C., Hövelmeyer, N., Kramer, D., & Heissmeyer, V. (2025) · European Journal of Immunology · doi:10.1002/eji.202451273 · Cited by 8
“The inhibitory effect of Regnase-1 can also be counteracted by Arid5a, which, during IL-17 stimulation, seems to interfere with Regnase-1 activity, stabilizes Nfkbiz mRNA, and promotes I κ B ζ protein expression [57].”
Cell‐intrinsic mechanisms to restrain inflammatory responses in T lymphocytes
Džafo, E., Bianchi, N., & Monticelli, S. (2021) · Immunological Reviews · doi:10.1111/imr.12932 · Cited by 8
Pancreatic Epithelial IL17/IL17RA Signaling Drives B7-H4 Expression to Promote Tumorigenesis
Castro-Pando, S., Howell, R. M., Li, L., Mascaró, M., Faraoni, E. Y., Roux, O. L., Romanin, D., Tahan, V., Riquelme, E. M., Zhang, Y., et al. (2024) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-23-0527 · Cited by 7
“Furthermore, as mRNA stabilization is another way in which IL17 can activate posttranscriptional pathways (55), we tested the ability of IL17 to prolong the half-life of Vtcn1 transcript.”
C/EBPδ Mediates Immunity to Renal Autoinflammatory Disorders in a Stage-specific Manner
Dey, I., Li, Y., Taylor, T. C., Peroumal, D., Asada, N., Panzer, U., Biswas, P. S., Sterneck, E., & Gaffen, S. L. (2024) · The Journal of Immunology · doi:10.4049/jimmunol.2400124 · Cited by 6
Self-citationRNA Metabolism Governs Immune Function and Response
Yoshinaga, M., & Takeuchi, O. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-981-99-9781-7_10 · Cited by 6
Xu, S., Kong, J., Li, H., Xie, H., Wang, F., Zhou, T., Zhang, X., Yu, L., Xu, S., & Pan, F. (2021) · Clinical and Experimental Medicine · doi:10.1007/s10238-021-00719-7 · Cited by 6
Altieri, A., Lloyd, D., Ramotar, P., van der Does, A. M., Hemshekhar, M., & Mookherjee, N. (2025) · Journal of Inflammation · doi:10.1186/s12950-025-00446-w · Cited by 7
“As IL-17 signaling and Regnase-1 are known to engage the NF-κB pathway [23, 44, 46], we also examined the abundance of NF-κB p65 and the phosphorylation of p-IKKα/β (S176/180), which is required for the activation of IKK kinases and subsequent NF-κB activation, by Western blots in human PBEC.”
InfluentialAct1 drives chemoresistance via regulation of antioxidant RNA metabolism and redox homeostasis
Hong, L., Herjan, T., Chen, X., Zagore, L. L., Bulek, K., Wang, H., Yang, C. J., Licatalosi, D. D., Li, X., & Li, X. (2024) · The Journal of Experimental Medicine · doi:10.1084/jem.20231442 · Cited by 5
CHOP-mediated IL-23 overexpression does not drive colitis in experimental spondyloarthritis
Navid, F., Gill, T., Fones, L., Allbritton‐King, J. D., Zhou, K., Shen, I., Doorn, J. V., Licausi, F., Cougnoux, A., Randazzo, D., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-62940-0 · Cited by 5
“NFKBIZ expression is stimulated by TLR activation and cytokines like IL-17A and IL-1 45–47 .”
BackgroundMultifunctional RNase MCPIP1 and its Role in Cardiovascular Diseases
Yan, B., Guo, Y., Gui, Y., Jiang, Z., & Zheng, X. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327999201113100918 · Cited by 5
Arid5a makes the IL-17A/F–responsive pathway less arid
Puel, A., & Casanova, J. (2018) · Science Signaling · doi:10.1126/scisignal.aau8876 · Cited by 4
Hepatocyte iron suppresses liver fibrosis via fibrolytic neutrophil recruitment in cholestasis
Kanamori, Y., Nita, A., Nakayama, K. I., Kurotaki, D., Harada, K., & Moroishi, T. (2025) · JHEP Reports · doi:10.1016/j.jhepr.2025.101590 · Cited by 4
“42,43 Although recent studies demonstrated that CXCL5 expression is transcriptionally upregulated via the recruitment of SOX2 and YAP to the Cxcl5 promoter in lung cancer cells, 44,45 the molecular mechanism underlying the regulation of CXCL5 transcription in the liver remains unknown.”
Bohár, B., Thomas, J. P., Liu, Y., Brooks-Warburton, J., Verstockt, B., Powell, N., Korcsmáros, T., & Módos, D. (2025) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izaf173 · Cited by 6
Li, Y., Xu, Z., Zhang, X., Zhang, Z., Ji, C., Guo, X., Zhang, J., Feng, P., Mao, R., Liu, Z., et al. (2026) · Inflammation Research · doi:10.1007/s00011-025-02159-5 · Cited by 2
“Our findings of increased Act1 protein and polysome-associated Act1 mRNA are consistent with this paradigm [ 37].”
The RNA binding protein Arid5a is an activator of TNF signaling in rheumatoid arthritis
Li, Y., Dey, I., Vyas, S., Synackova, A., Decheng, L. I., Lubberts, E., Ascherman, D. P., Dráber, P., & Gaffen, S. L. (2026) · JCI Insight · doi:10.1172/jci.insight.196411 · Cited by 3
Self-citationThe tissue-specific regulation of immunobiology by IL-17 signaling
Li, Y., Vyas, S., Dráber, P., Bechara, R., & Gaffen, S. L. (2026) · Science Immunology · doi:10.1126/sciimmunol.adq6406 · Cited by 2
Self-citationRole of tyrosine kinase 2 signals during progression of psoriasis
Muromoto, R., Oritani, K., & Matsuda, T. (2022) · Exploration of Immunology · doi:10.37349/ei.2022.00081 · Cited by 2
Ren, Z., Huang, W., Gu, X., & Zhao, L. (2025) · Burns & Trauma · doi:10.1093/burnst/tkaf012 · Cited by 1
“Arid5a could both recognized stem–loop structures in the 3’UTR of STAT3 and counteracting the RNase function of Regnase-1 to maintain the mRNA level [14].”
Innate lymphoid cells integrate sensing and plasticity to control fungal infections
Tsymala, I., Penninger, P., Nogueira, F., Jenull, S., Phan-Canh, T., Brezovec, H., Teufl, M., Miranda, S., Ellmeier, W., Boucheron, N., et al. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117140 · Cited by 1
Sarah Gaffen: I thrive on turning my vision for the lab into reality
Emmenis, L. V. (2024) · The Journal of Experimental Medicine · doi:10.1084/jem.20241418
The role of MCPIP1 protein in keratinocytes stress response
Bugara, B. (n.d.) · Jagiellonian University Repository (Jagiellonian University)
Decheng, L. I., Reay, D. P., Li, Y., Vyas, S., Yamamoto, K., Ascherman, D. P., & Gaffen, S. L. (2026) · The Journal of Immunology · doi:10.1093/jimmun/vkag225
“42,43 The following Abs were used for immunoblotting: anti-I κ B f (Cell Signaling, 93726S), anti– β -actin (Abcam, ab49900), anti-YY1 (Santa Cruz Biotechnology, sc1703), and anti– α -tubulin (Abcam, ab40742).”
Self-citationTh17 cells and IL-17A in traumatic brain injury: mechanisms and therapeutic perspectives
Guo, X., Wang, J., Zhu, S., Sun, B., Tian, L., Li, M., Feng, S., & Sun, G. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1850719 · Cited by 1
“RNA-binding proteins such as Arid5a regulate in fl ammatory mRNA stability and can enhance IL-17-driven gene expression, whereas Act1-dependent ubiquitination facilitates TRAF6 recruitment and downstream signaling (68, 71, 72).”
Extending the reach of transcription factors to mRNA stability
Galvan, B., Ongena, L., Claes, M., Mariavelle, E., & Dequiedt, F. (2026) · Trends Open · doi:10.1016/j.treopn.2026.07.017
Targeting the IL-17A Cytokine Interface: Structural Insights and Small-Molecule Modulators
Kim, G. U., Lee, A., Lee, S., Jeon, B., Park, H., Kang, T., & Choo, H. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6c01296
From iron sequestration to immune paralysis: A biphasic model of Lipocalin-2 function in sepsis
Cauvi, D. M., & Maio, A. D. (2026) · Innate Immunity · doi:10.1177/17534259261506889
Metadata
- Authors
- Amatya, N., Childs, E. E., Cruz, J. A., Aggor, F. E. Y., Garg, A. V., Berman, A. J., Gudjonsson, J. E., Atasoy, U., & Gaffen, S. L.
- Affiliations
- University of Pittsburgh (US)
- University of Michigan (US)
- Corresponding author
- Gaffen, Sarah L.
- ORCID
- Venue
- Science Signaling
- Published
- 2018-10-09
- Volume
- 11
- Issue
- 551
- ISSN
- 1937-9145 (ISSN-L)
- 1945-0877
- PMC
- PMC6188668
- OpenAlex
- W2896648763
- Cited by
- 75
- References
- 64
- Citations by year
- 2026: 8 · 2025: 6 · 2024: 12 · 2023: 7 · 2022: 13 · 2021: 8 · 2020: 9 · 2019: 11 · 2018: 1
- FWCI
- 3.12
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science Signaling (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of General Medical Sciences (GM116889)
- National Institute of Allergy and Infectious Diseases (AI107825, AI080870, AI128991)
- National Institute of Dental and Craniofacial Research (DE022550, DE023815)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- IL-17 signaling, Arid5a, RNA-binding proteins, feed-forward loop, self-reinforcing mechanisms, mRNA stability, translational regulation
- MeSH terms
- Animals, DNA-Binding Proteins, Fibroblasts, Humans, Inflammation, Mice, Inbred C57BL, Nuclear Proteins, Protein Binding, Ribonucleases, RNA, Messenger, Transcription Factors, Signal Transduction, Keratinocytes, Cytokines, RNA-Binding Proteins, Mice, Knockout, Interleukin-17, 3' Untranslated Regions, CCAAT-Enhancer-Binding Protein-beta, TNF Receptor-Associated Factor 2, Adaptor Proteins, Signal Transducing, Mice, HEK293 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.